Option Agreement Sample Contracts

AudioEye – Performance Option Agreement (March 27th, 2019)

This Performance Option Agreement (this "Agreement") is made and entered into as of ________________ (the "Grant Date") by and between AudioEye, Inc., a Delaware corporation (the "Company") and _____________ (the "Grantee").

Option Agreement (March 18th, 2019)

This OPTION AGREEMENT, dated as of March 14, 2019 (this "Agreement"), is made by and between Cadiz Inc., a Delaware corporation ("Cadiz"), and Elkhorn Partners Limited Partnership, (the "Noteholder").

Option Agreement (March 18th, 2019)

This OPTION AGREEMENT, dated as of March 14, 2019 (this "Agreement"), is made by and between Cadiz Inc., a Delaware corporation ("Cadiz"), and WPI-Cadiz Farm CA, LLC (the "Noteholder").

Option Agreement (March 18th, 2019)

This OPTION AGREEMENT, dated as of March 14, 2019 (this "Agreement"), is made by and between Cadiz Inc., a Delaware corporation ("Cadiz"), and Nokomis Capital Master Fund, L.P., a Texas limited liability company, (the "Noteholder").

Exclusive Equity Purchase and Transfer Option Agreement (March 15th, 2019)
Amended and Restated Exclusive Equity Purchase and Transfer Option Agreement (March 15th, 2019)
Amended and Restated Exclusive Equity Purchase and Transfer Option Agreement (March 15th, 2019)
Exclusive Equity Purchase and Transfer Option Agreement (March 15th, 2019)
Change Healthcare Inc. – The Board Believes This Ensures That You Will Have the Opportunity to Realize the Value of Your Performance Options Even if McKesson and Blackstone Elect to Sell or Distribute Their Investment at a Valuation Lower Than $4,200 Per Share. Except as Provided in This Letter, the Option Agreement Shall Remain Unchanged and Continue in Full Force and Effect. Therefore, if Blackstone Sells More Than 25% of Its JV Shares for $4,300 and McKesson Has Distributed More Than 50% of Their JV Shares by That Time as Well, Then 100% of Your Performance Options Would Vest. If You Have Any Questions, Please Cont (March 15th, 2019)
MMEX Mining Corp – Option Agreement (March 12th, 2019)

WHEREAS, the Company has entered into that certain Securities Purchase Agreement as of October 5, 2018 (the "SPA"), with GS Capital Partners, LLC (the "Lender") which also included a loan advance to the Company; and

Geron Corporation 2018 Inducement Award Plan Option Agreement (Nonstatutory Stock Option) (March 7th, 2019)

Pursuant to your Stock Option Grant Notice ("Grant Notice") and this Option Agreement, Geron Corporation (the "Company") has granted you an option under its 2018 Inducement Award Plan (the "Plan") to purchase the number of shares of the Company's Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. The option is granted to you effective as of the date of grant set forth in the Grant Notice (the "Date of Grant"). If there is any conflict between the terms in this Option Agreement and the Plan, the terms of the Plan will control. Capitalized terms not explicitly defined in this Option Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.

Thunder Mountn Gold – OPTION AGREEMENT Made Between (March 4th, 2019)
Jufeel International Group – Exclusive Equity Option Agreement (February 21st, 2019)

This Exclusive Equity Option Agreement (this "Agreement") is entered into as of July 27, 2017 in Kaifeng, People's Republic of China ("PRC") by and among the following persons:

Notice of Grant of Nonqualified Stock Options and Option Agreement (February 15th, 2019)

Effective ______________, you have been granted a Nonqualified Stock Option to buy ________ shares of Common Stock of Quidel Corporation (the "Company") at $_____ per share, pursuant to Section 6.1 of the Quidel Corporation 2018 Equity Incentive Plan (the "Plan").

Regeneron Pharmaceuticals, Inc. ID: [ ] Notice of Grant of Stock Options 777 Old Saw Mill River Road and Option Agreement for Time-Based Vesting Tarrytown, New York 10591 Option Awards [OPTIONEE NAME] Option Number: [OPTIONEE ADDRESS] Plan: ID: (February 7th, 2019)

Effective <date> (the "Grant Date") you have been granted a Non-Qualified Option to buy [ ] shares of Regeneron Pharmaceuticals, Inc. (the "Company") stock at $[ ] per share.

Lexaria Corp – Warrant and Option Agreement (January 22nd, 2019)

This Warrant and Option Agreement ("Agreement") is executed as of January 15, 2019, by Lexaria Nicotine LLC, a Delaware limited liability company (the "Company") and Lexaria Bioscience Corp., a Nevada corporation ("Company Holdings"), in favor of Altria Ventures Inc., a Virginia corporation (the "Initial Holder"), in accordance with the terms and subject to the conditions set forth in this Agreement. The Company, Company Holdings and the Initial Holder are each referred to herein as a "Party" and collectively as the "Parties."

Positive Physicians Holdings,Inc. – Option Agreement (January 22nd, 2019)

This OPTION AGREEMENT (this "Agreement") is entered into as of [*], 201__, among Insurance Capital Group, LLC, a Delaware limited liability company ("ICG"), ________________,1 a ________________ ("___" and, together with ICG, the "Positive Shareholders"), Diversus, Inc., a Delaware corporation ("Diversus"), and Positive Physicians Holdings, Inc., a Pennsylvania corporation ("Positive").

United World Holding Group Ltd. – Equity Option Agreement (January 18th, 2019)

This Equity Option Agreement (this "Agreement") is executed by and among the following Parties as of December 5, 2018 in Beijing, the People's Republic of China ("China" or the "PRC"):

Alector, Inc. – SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE CONFIDENTIAL TREATMENT FOR THOSE TERMS HAS BEEN REQUESTED. THE REDACTED MATERIAL HAS BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION, AND THE TERMS HAVE BEEN MARKED AT THE APPROPRIATE PLACE WITH THREE ASTERISKS [***]. CO- DEVELOPMENT AND OPTION AGREEMENT Between ALECTOR, INC. And ABBVIE BIOTECHNOLOGY, LTD. Dated as of October 16, 2017 (January 7th, 2019)
Stealth BioTherapeutics Corp – STEALTH BIOTHERAPEUTICS CORP Nonstatutory Option Agreement (December 28th, 2018)
You On Demand Holdings Inc – Share Purchase and Option Agreement (November 14th, 2018)

This SHARE PURCHASE AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this "Agreement"), dated July 16, 2018, is entered into by and between Seven Stars Cloud Group, Inc., a corporation incorporated under the laws of Nevada (the "Company"), and Star Thrive Group Limited , a company incorporated and existing under the laws of the British Virgin Islands (the "Purchaser").

Synthorx, Inc. – Research Funding and Option Agreement (November 13th, 2018)
Surface Oncology, Inc. – First Amended and Restated Development and Option Agreement (November 13th, 2018)

This First Amended and Restated Development and Option Agreement (this "Agreement") made effective as of October 3, 2018 (the "Amended Effective Date"), is entered into by and between Adimab, LLC, a Delaware limited liability company having an address at 7 Lucent Drive, Lebanon, NH 03766 ("Adimab"), and Surface Oncology, Inc., a Delaware corporation having an address at 25 First Street, Suite 303, Cambridge, MA 02141 ("Surface").

Option Agreement (November 13th, 2018)
OPTION AGREEMENT Made as of _____, __, _____ (November 13th, 2018)
CatchMark Timber Trust, Inc. – Option Agreement (November 1st, 2018)

THIS OPTION AGREEMENT (this "Agreement"), made as of the Effective Date (as defined in paragraph 26 below), by and among LRT III LLC, a Delaware limited liability company (hereinafter referred to as "Seller"), CATCHMARK TIMBER TRUST, INC., a Maryland corporation (hereinafter referred to as "Purchaser").

OPTION AGREEMENT This Agreement Dated as of the * Day of *, *, BETWEEN: DIAMEDICA THERAPEUTICS INC. A Corporation Incorporated Under the Laws of Canada, (Hereinafter Called the "Corporation"), OF THE FIRST PART, - And - Of the * of *, in the * of *, (Hereinafter Called the "Participant"), OF THE SECOND PART. (November 1st, 2018)

WHEREAS the Participant is a bona fide Senior Officer, Director, Employee, Management Company Employee or Consultant of the Corporation or any subsidiary of the Corporation;

Drdgold Limited – DRD OPTION AGREEMENT Between DRDGOLD LIMITED and SIBANYE GOLD LIMITED (October 31st, 2018)
Stealth BioTherapeutics Corp – STEALTH BIOTHERAPEUTICS CORP Nonstatutory Option Agreement (October 26th, 2018)
Alector, Inc. – SPECIFIC TERMS IN THIS EXHIBIT HAVE BEEN REDACTED BECAUSE CONFIDENTIAL TREATMENT FOR THOSE TERMS HAS BEEN REQUESTED. THE REDACTED MATERIAL HAS BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION, AND THE TERMS HAVE BEEN MARKED AT THE APPROPRIATE PLACE WITH THREE ASTERISKS [***]. CO- DEVELOPMENT AND OPTION AGREEMENT Between ALECTOR, INC. And ABBVIE BIOTECHNOLOGY, LTD. Dated as of October 16, 2017 (October 12th, 2018)
Wadena Corp. – Option Agreement (September 27th, 2018)
Wadena Corp. – Option Agreement (September 27th, 2018)
VistaGen Therapeutics, Inc. – Option Agreement (September 13th, 2018)

This Option Agreement ("Agreement"), effective on September 11, 2018 (the "Effective Date"), is by and between Pherin Pharmaceuticals, Inc., a California corporation with offices at 1014 Barbara Avenue, Mountain View, CA 94040 ("SELLER"), and VistaGen Therapeutics, Inc., a Nevada corporation with offices at 343 Allerton Avenue, South San Francisco, California 94080 ("BUYER"). BUYER and SELLER are sometimes referred to separately as a "Party" and collectively as the "Parties.

Wadena Corp. – Option Agreement (September 11th, 2018)
Wadena Corp. – Option Agreement (September 11th, 2018)